# Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density

> **NCT00102908** · PHASE2 · UNKNOWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 30 (estimated)

## Conditions studied

- HIV Infections
- Osteopenia
- Osteoporosis

## Interventions

- **DRUG:** Zoledronate
- **DRUG:** Zoledronate placebo

## Key facts

- **NCT ID:** NCT00102908
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-05
- **Primary completion:** 2007-10
- **Final completion:** 2009-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2008-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00102908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00102908, "Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00102908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*